Literature DB >> 7525495

The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis.

P Castellani1, G Viale, A Dorcaratto, G Nicolo, J Kaczmarek, G Querze, L Zardi.   

Abstract

Different fibronectin (FN) isoforms are generated by the alternative splicing of 3 regions (ED-A, ED-B and IIICS) of the primary transcript. The FN isoform containing the ED-B sequence, a complete type-III-homology repeat, while having extremely restricted distribution in normal adult tissues, reveals high expression in fetal and tumor tissues. Using the monoclonal antibody (MAb) BC-I, specific for the FN isoform containing the ED-B sequence (B+.FN), we demonstrated here, using immunohistochemical techniques, that while this FN isoform is undetectable in mature vessels, it is highly expressed during angiogenesis both in neoplastic and in normal tissues, as in the case of the functional layer of endometrium during the proliferative phase. B+.FN is thus a marker for the formation of new vessels, and the BC-I MAb may be a useful reagent for evaluating the level of the angiogenetic process in different neoplasms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7525495     DOI: 10.1002/ijc.2910590507

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  69 in total

Review 1.  Molecular targeting of angiogenesis for imaging and therapy.

Authors:  Simon S Brack; Ludger M Dinkelborg; Dario Neri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-08-05       Impact factor: 9.236

2.  Nanobody-based CAR T cells that target the tumor microenvironment inhibit the growth of solid tumors in immunocompetent mice.

Authors:  Yushu Joy Xie; Michael Dougan; Noor Jailkhani; Jessica Ingram; Tao Fang; Laura Kummer; Noor Momin; Novalia Pishesha; Steffen Rickelt; Richard O Hynes; Hidde Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-01       Impact factor: 11.205

3.  Use of uteroglobin for the engineering of polyvalent, polyspecific fusion proteins.

Authors:  Elisa Ventura; Francesca Sassi; Sara Fossati; Arianna Parodi; William Blalock; Enrica Balza; Patrizia Castellani; Laura Borsi; Barbara Carnemolla; Luciano Zardi
Journal:  J Biol Chem       Date:  2009-07-24       Impact factor: 5.157

Review 4.  Biology of angiogenesis and invasion in glioma.

Authors:  Matthew C Tate; Manish K Aghi
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

Review 5.  Embryonic angiogenesis: a review.

Authors:  J Wilting; B Christ
Journal:  Naturwissenschaften       Date:  1996-04

6.  Biodistribution studies with tumor-targeting bispecific antibodies reveal selective accumulation at the tumor site.

Authors:  Thomas List; Dario Neri
Journal:  MAbs       Date:  2012-10-02       Impact factor: 5.857

7.  Increased expression of fibronectin and the alpha 5 beta 1 integrin in angiogenic cerebral blood vessels of mice subject to hypobaric hypoxia.

Authors:  Richard Milner; Stephanie Hung; Bernadette Erokwu; Paula Dore-Duffy; Joseph C LaManna; Gregory J del Zoppo
Journal:  Mol Cell Neurosci       Date:  2008-02-13       Impact factor: 4.314

8.  Alternative splicing of the angiogenesis associated extra-domain B of fibronectin regulates the accessibility of the B-C loop of the type III repeat 8.

Authors:  Elisa Ventura; Francesca Sassi; Arianna Parodi; Enrica Balza; Laura Borsi; Patrizia Castellani; Barbara Carnemolla; Luciano Zardi
Journal:  PLoS One       Date:  2010-02-10       Impact factor: 3.240

Review 9.  Proinsulin C-peptide: friend or foe in the development of diabetes-associated complications?

Authors:  Lina Nordquist; M Johansson
Journal:  Vasc Health Risk Manag       Date:  2008

10.  Alternative splicing and tumor progression.

Authors:  Claudia Ghigna; Cristina Valacca; Giuseppe Biamonti
Journal:  Curr Genomics       Date:  2008-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.